"Drotrecogin alfa (activated) treatment in severe sepsis from the global" by Jay Steingrub, MD

Selected Works of Jay Steingrub MD

Follow Contact

Article

Drotrecogin alfa (activated) treatment in severe sepsis from the global

All Scholarly Works

Jay Steingrub, MD, Baystate Health

Document Type

Article, Peer-reviewed

Publication Date

10-1-2005

Abstract

OBJECTIVE: To provide further evidence for the efficacy and safety of drotrecogin alfa (activated) treatment in severe sepsis. DESIGN: Single-arm, open-label, trial of drotrecogin alfa (activated) treatment in severe sepsis patients. Enrollment began in M

Publication ISSN

1478-9515

Citation Information

Crit Care Med. 2005 Oct;33(10):2266-77.